slide1
Download
Skip this Video
Download Presentation
IRC New Proposals Recommendations Board Alliance Meeting, November 2007 Cape Town Dr. Frank Nyonator – IRC member

Loading in 2 Seconds...

play fullscreen
1 / 13

IRC New Proposals Recommendations Board Alliance Meeting, November 2007 Cape Town Dr. Frank Nyonator – IRC member - PowerPoint PPT Presentation


  • 226 Views
  • Uploaded on

IRC New Proposals Recommendations Board Alliance Meeting, November 2007 Cape Town Dr. Frank Nyonator – IRC member. Summary 1. 2. Summary 2: Total new support recommended for approval: US$ 428,615,500.

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'IRC New Proposals Recommendations Board Alliance Meeting, November 2007 Cape Town Dr. Frank Nyonator – IRC member' - Philip


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
slide1
IRC New Proposals Recommendations

Board Alliance Meeting, November 2007

Cape Town

Dr. Frank Nyonator – IRC member

summary 2 total new support recommended for approval us 428 615 500
Summary 2: Total new support recommended for approval: US$ 428,615,500

Of the US399,622,500 recommended for vacccine support, 5,438,000 is introduction grants and US 394,184,500 is for new vaccines

review results of immunization services support iss
Review results of Immunization Services Support (ISS)
  • Total multiyear funding request of nearly $29 million
  • The IRC recommends for approval all 8 requests: Comoros, Congo DR, Ethiopia, Kenya, Lesotho, Liberia, Nepal, Nicaragua
  • If approved, funding will be used to reach an additional 1.44 million children with 3 doses of DTP vaccine
review results of new vaccines support nvs
Review results of New Vaccines Support (NVS)
  • If approved, this means reaching a total of 34 million children with these 5 vaccines in 2008-12.

5

countries co financing for new vaccines
Countries co-financing for new vaccines
  • Distribution of recommended approvals among co-financing groups: 25% Least poor; 20% intermediate; 35% Poorest; 20% fragile.
  • All countries have committed to pay the minimum or higher level of co-financing and have indicated the month of payment.
  • The co-financing requirement has not discouraged countries’ new vaccine applications.
  • If the Board approves these requests for NVS, during 2008 – 2012 countries are committed to co-finance US$ 33.5 million of which US $4.8 will be contributed by 5 countries with GNI per capita of less than a dollar a day (CAR, Togo, Madagascar, Niger, Congo DR).
slide9
Quality of country proposals improved during 2007

Note: Analysis based on 15 new proposals for NVS submitted in May and 16 new proposals for NVS submitted in October

best practice effective technical assistance to francophone countries in africa
Best practice: effective Technical Assistance to francophone countries in Africa
  • The successful outcome of this review is strongly associated to the technical assistance provided by partners like WHO
    • Last May, five proposals from countries in francophone Africa received conditional approval for new vaccines introduction
    • WHO regional office organized a workshop for the 5 countries to help them to address the conditions and share best-practices.
  • As a result, all 5 countries were recommended for full approval in the October round.
slide12
Board request
  • The Boards are requested to approve multi-year country programmes and endorse corresponding budgets totalling US$ 428,615,500.
  • Specifically:
    • New Vaccines Support totalling US$ 399,622,500
    • ISS support totalling US$ 28,993,000

12

ad